ClinicalTrials.Veeva

Menu

The Effect of Surfactant Administration on Cerebral Oxygenation

Z

Zekai Tahir Burak Women's Health Research and Education Hospital

Status

Suspended

Conditions

Prematurity
Respiratory Distress Syndrome

Treatments

Device: near infrared spectroscopy (INVOS 5100)

Study type

Observational

Funder types

Other

Identifiers

NCT01258517
NIRS-018

Details and patient eligibility

About

The purpose of this study is to assess changes in cerebral oxygenation during two different types (beractant and poractant) and two different routes (double lumen or single lumen endotracheal tube) of surfactant administration using near infrared spectroscopy (NIRS).

Enrollment

40 estimated patients

Sex

All

Ages

23 to 32 weeks old

Volunteers

No Healthy Volunteers

Inclusion criteria

Clinical diagnosis of respiratory distress syndrome <32 gestational weeks and/or <1500 g birthweight

Exclusion criteria

major congenital anomalies complex congenital heart diseases

Trial design

40 participants in 1 patient group

group 1, group 2, group 3, group 4
Description:
administration of beractant with single lumen ET tube administration of poractant with single lumen ET tube administration of beractant with double lumen ET tube administration of poractant with double lumen ET tube
Treatment:
Device: near infrared spectroscopy (INVOS 5100)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems